Our innovative therapies treat extremely rare and life-threatening diseases. Our portfolio of specialist therapies includes products that are available in 68 countries around the world.
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard.
Adverse events should also be reported to Shire Pharmaceuticals Ltd on 01256 894000 or emailed to email@example.com.
If you are a health care professional, you can contact Shire Medical Information by medinfoEMEA@shire.com.
BUCCOLAM 2.5 mg, 5 mg, 7.5 mg and 10 mg Oromucosal Solution Alert
Please click here for information and guidance for healthcare professionals regarding the Buccolam tip-cap issue and correct use of the product.
View and search our list of products currently on the market.